Efficacy and Safety of Transarterial Therapies+Donafenib + Anti-PD-1 Antibody for uHCC: A Retrospective Real-world Study
Clinical trial NCT05638438 · UNKNOWN
Trial details
- NCT number
- NCT05638438
- Sponsor
- Zhujiang Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-12-02
- Primary completion
- 2023-06-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.